A research team has discovered a highly potent biomarker for clinical response to CAR-T cell therapy, describing the prerequisites for optimal use of this novel therapy for lymphoma treatment. The current findings are an essential step forward towards optimizing this promising therapy.
from Top Health News -- ScienceDaily https://ift.tt/cEMD2Fm
No comments:
Post a Comment